Bioinformatics Exploration of the Therapeutic Potential of Lotus Seed Compounds in Multiple Sclerosis: A Network Analysis of c‐Jun Pathway
- 5 January 2025
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 86 (1) , e70038
Abstract
The central nervous system is affected by multiple sclerosis (MS), a chronic autoimmune illness characterized by axonal destruction, demyelination, and inflammation. This article summarizes the state of the field, highlighting its complexity and significant influence on people's quality of life. The research employs a network pharmacological approach, integrating systems biology, bioinformatics, and pharmacology to identify biomarkers associated with MS. Utilizing Nelumbo Nucifera (Lotus) seeds, the study involves toxicity assessments, biomolecule screening, and target prediction. Advanced computational methodologies are employed, including molecular docking and dynamic simulations, to assess potential therapeutic interactions. Biomolecule screening identifies eight active compounds from Lotus seeds, including Anonaine and Liriodenine. Target prediction reveals 264 common targets with MS‐related genes. Protein‐protein interaction analysis establishes a complex network, identifying central targets like SRC and AKT1. Bioinformatics enrichment analysis uncovers potential therapeutic candidates and pathways. A Biomolecule‐Target‐Pathway network diagram visualizes interactions, with Anonaine and Liriodenine exhibiting strong binding affinities in molecular docking studies. Molecular dynamics simulations provide insights into dynamic interactions. In conclusion, through advanced computational techniques, it unveils molecular interactions, potential therapies, and pathways, bridging predictions with practical applications. Anonaine and Liriodenine show promise in curbing MS biomarkers.Keywords
Funding Information
- King Saud University
This publication has 58 references indexed in Scilit:
- Insights into Vitamin E with Combined Oral Contraceptive on INSR Gene in PCOS by Integrating In Silico and In Vivo ApproachesApplied Biochemistry and Biotechnology, 2023
- Bruton’s Tyrosine Kinase Inhibition in Multiple SclerosisCurrent Neurology and Neuroscience Reports, 2022
- Network pharmacology-based analysis of the anti-hyperglycemic active ingredients of roselle and experimental validationComputers in Biology and Medicine, 2022
- Siponimod for multiple sclerosisCochrane Database of Systematic Reviews, 2021
- Understanding Abnormal c-JNK/p38MAPK Signaling Overactivation Involved in the Progression of Multiple Sclerosis: Possible Therapeutic Targets and Impact on Neurodegenerative DiseasesNeurotoxicity Research, 2021
- In Silico and In Vivo Toxicological Evaluation of PaeonolChemistry & Biodiversity, 2020
- BBB-permeable aporphine-type alkaloids in Nelumbo nucifera flowers with accelerative effects on neurite outgrowth in PC-12 cellsJournal of Natural Medicines, 2019
- Oxidative damage and the Nrf2-ARE pathway in neurodegenerative diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014
- Epigenetics of Multiple Sclerosis: An Updated ReviewNeuroMolecular Medicine, 2014
- Promoting Remyelination in Multiple Sclerosis—Recent AdvancesDrugs, 2013